Dynavax (DVAX) to Discuss Phase 3 HEPLISAV-B via Conf. Call on Jan. 7th
Tweet Send to a Friend
Dynavax Technologies Corporation (NASDAQ: DVAX) will host a conference call and webcast tomorrow morning, January 7, 2016, at 8:30 a.m ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
